Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/1997
02/26/1997EP0759037A1 Antigen/antibody specificity exchanger
02/26/1997EP0759036A1 Immunointeractive molecules-i
02/26/1997EP0759034A1 Peptides for diagnostics and therapeutics
02/26/1997EP0759033A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
02/26/1997EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
02/26/1997EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
02/26/1997EP0570554A4 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state
02/26/1997EP0552267B1 Engineered bacteriophages and vaccines containing them
02/26/1997CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r
02/25/1997USRE35465 Method and agents for removing advanced glycosylation endproducts
02/25/1997US5606044 Using nucleic acid probes
02/25/1997US5606043 Methods for the diagnosis of glaucoma
02/25/1997US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification
02/25/1997US5606030 Coconjugates of OMPC, HIV related peptides and anionic moieties
02/25/1997US5606028 Anchimeric radiometal chelating compounds
02/25/1997US5606027 Antibodies to a neutrophil chemotactic protein
02/25/1997US5606026 Natural human IgM antibodies immunoreactive with the Tat protein of HIV-1
02/25/1997US5606017 Antitumor agents
02/25/1997US5605831 Human melanoma cell specific antigens and antibodies
02/25/1997US5605830 Cancer diagnosis, therapy
02/25/1997US5605821 Expression control sequences of the P-selectin gene
02/25/1997US5605814 DNA encoding human prostaglandin receptor EP2
02/25/1997US5605811 Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
02/25/1997US5605810 NADH oxidase assay for neoplasia determination
02/25/1997US5605808 Oncoprotein protein kinase
02/25/1997US5605803 Human sperm diagnostic
02/25/1997US5605802 Method for identifying agents which block infection of cells by HIV
02/25/1997US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites
02/25/1997US5605793 Adding to cleaved random double stranded fragments one or more single stranded or double stranded oligonucleotides, denaturing into single stranded fragments, incubating
02/25/1997US5605691 Immunologically active proteins from inclusion bodies
02/25/1997US5605689 Treatment of HIV-associated immune thrombocytopenic purpura
02/25/1997US5605688 Recombinant dog and horse type I interferons
02/25/1997CA2184046A1 Pharmaceutical compositions containing a neutralized virus and use thereof
02/25/1997CA2110916C Reagents and methods for the quantification of imipramine or disipramine in biological fluids
02/20/1997WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes
02/20/1997WO1997006256A2 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
02/20/1997WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
02/20/1997WO1997006251A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-α RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-α AND ITS ANALOGUES
02/20/1997WO1997006184A1 Antibody that recognizes serum amyloid a
02/20/1997WO1997006166A1 Quinidine conjugates and their use in immunoassays
02/20/1997WO1997005901A1 Targeting of organs by immunoconjugates
02/20/1997WO1996038571A3 Recombinant polypeptide cytotoxins for cancer treatment
02/20/1997CA2512366A1 Mammalian iap gene family, primers, probes and detection methods
02/20/1997CA2228999A1 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
02/20/1997CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes
02/19/1997EP0758656A2 Immunoglobulin activated by mixing with a histamine component
02/19/1997EP0758394A1 Bifunctional protein, preparation and use
02/19/1997EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
02/19/1997EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof
02/19/1997CN1143386A Transforming growth factor alpha-H1
02/19/1997CN1143374A Non-viral vector
02/19/1997CN1143373A 乙型肝炎疫苗 Hepatitis B Vaccine
02/19/1997CN1143372A Haemopoietic manuration factor
02/19/1997CN1143371A Corpuscles of stannius protein, stanniocalcin
02/19/1997CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases
02/19/1997CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region
02/18/1997USRE35457 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
02/18/1997US5604126 Used to identify endothelial cells in diseased tissue such as rheumatoid and osteoarthritis synovial tissues, psoriatic skin
02/18/1997US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody
02/18/1997US5604115 Liver enriched transcription factor
02/18/1997US5604107 Detection of neu p185 in cell lysates
02/18/1997US5604106 Testing a body fluid sample with anti-autocrine motility factor antibody
02/18/1997US5604105 Method and device for diagnosing and distinguishing chest pain in early onset thereof
02/18/1997US5604102 Detecting and monitoring a terminal fragment of the beta-amyloid precursor protein produced by beta-secretase cleavage; alzheimer's disease
02/18/1997US5604094 Receptor-type phosphotyrosine phosphatase-β
02/18/1997US5604092 Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein
02/18/1997US5603934 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy
02/18/1997US5603931 Administering hybrid reagent comprising first portion having affinity for cellular target and second portion having affinity for bioactive molecule, which can be selectively released in response to change in ph
02/13/1997WO1997005256A2 Mammalian pro-hormone convertase
02/13/1997WO1997005253A2 Transketolase-related protein
02/13/1997WO1997005250A2 Receptor ligand vegf-c
02/13/1997WO1997005244A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
02/13/1997WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
02/13/1997WO1997005170A2 Broad specificity antibodies
02/13/1997WO1997005169A1 Ha-2 antigenic peptide
02/13/1997WO1997005168A1 The h-y antigen
02/13/1997WO1997004862A1 Polyvinyl alcohol-based magnetic polymer particles, methods for their preparation and their use
02/13/1997WO1997004806A1 Remedy for neurological disorders
02/13/1997WO1997004794A1 Modulators of expression and function of lrp in alzheimer's disease
02/13/1997WO1996019588A3 Methods and reagents for detecting fungal pathogens in a biological sample
02/13/1997WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes
02/13/1997WO1996002572A3 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof
02/13/1997CA2246561A1 Modulators of expression and function of lrp in alzheimer's disease
02/13/1997CA2228248A1 Receptor ligand vegf-c
02/13/1997CA2227988A1 Mammalian pro-protein converting enzyme
02/13/1997CA2227972A1 Mocarhagin, a cobra venom protease and therapeutic uses thereof
02/13/1997CA2227599A1 Broad specificity antibodies
02/13/1997CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
02/13/1997CA2224909A1 Ha-2 antigenic peptide
02/13/1997CA2224894A1 The h-y antigen
02/12/1997EP0757716A1 Dna encoding bradykinin b 1? receptor
02/12/1997EP0757697A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
02/12/1997EP0757696A1 Human sperm diagnostic
02/12/1997EP0757689A1 Porphocyanine and cnc-expanded porphyrins
02/12/1997EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft
02/12/1997EP0470184B1 Antibodies specific for cd4-binding domain of hiv
02/12/1997EP0440777B1 Brain derived neurotrophic factor
02/12/1997CN1142855A Humanized antibodies and uses thereof
02/12/1997CN1142854A C5a receptor antagonists having substantially no agonist activity
02/12/1997CN1142775A Preparation and use of immunoconjugates